Critical role of interleukin (IL)-17 in inflammatory and immune disorders: An updated review of the evidence focusing in controversies
José María García Ruiz de Morales(Universidad de León), Miguel Á. González‐Gay(Universidad de Cantabria), Carlos González Juanatey(Hospital Universitario Lucus Augusti), Xavier Montalbán(Universitat de Vic - Universitat Central de Catalunya), L. Puig(Universitat Autònoma de Barcelona), E. Daudén(Hospital Universitario de La Princesa), Juan D. Cañete(Hospital Clínic de Barcelona), Guillermo Ortí(Hospital Universitari i Politècnic La Fe), Alfredo Adán(Consorci Institut D'Investigacions Biomediques August Pi I Sunyer), Natalia Borruel, Esther Holgado-Martín(Hospital Ruber Internacional), Carolina García‐Vidal(Hospital Clínic de Barcelona), Victor Martín(Novartis (Spain)), José L. Pablos(Research Institute Hospital 12 de Octubre), Cynthia Vizcaya-Morales(Novartis (Switzerland))
Cited by 334
Related Papers
Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria
|Annals of Neurology|2011|9.8k
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
|The Lancet Neurology|2017|8k
Enterotypes of the human gut microbiome
|Nature|2011|7.6k
Defining the clinical course of multiple sclerosis
|Neurology|2014|3.1k
Oral Fingolimod or Intramuscular Interferon for Relapsing Multiple Sclerosis
|New England Journal of Medicine|2010|2.2k